XELOX Combined With Apatinib as Post-operative Chemotherapy in Locally Advanced Gastric Adenocarcinoma
Clinical trial NCT03599778 · UNKNOWN
Trial details
- NCT number
- NCT03599778
- Sponsor
- Anhui Provincial Hospital
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-01
- Primary completion
- 2025-01-30
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.